NuVasive Revenue, Profits - NUVA Quarterly Income Statement

Add to My Stocks
$65.64 $0.11 (0.17%) NUVA stock closing price Oct 15, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking NuVasive stock price alone is not sufficient. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $281.56M for 2018 Q2 impacts the NUVA stock. Investors typically check year over year or quarter over quarter revenue growth. One also needs to look at NuVasive assets, operating expenses and NuVasive free cash flow. The NuVasive profit and loss statement shows revenue of $281.56M for 2018 Q2. Revenue has grown by 8.08% QoQ for NUVA stock.

View and download details of revenue and profits for NuVasive for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
NuVasive Revenues or Net Sales
Cost Of Goods Sold (COGS)77.05M73.81M75.39M65.58M66.42M61.61M66.94M59.19M59.74M
NuVasive Gross Profit
Research & Development Expense14.85M14.49M12.72M12.72M12.57M12.41M12.99M12.51M11.87M
Selling General & Admin Expense148.46M178.01M140.79M126.89M140.47M140.55M149.05M135.33M93.93M
Income Before Depreciation Depletion Amortization41.19M-5.79M42.77M42.23M41.1M35.28M42.17M32.59M70.66M
Depreciation Depletion Amortization12.62M12.42M13M11.63M11.34M12.06M12.1M11.43M10.6M
Non Operating Income-2.26M-9.56M-1.08M-0.05M-0.36M--1.67M--
Interest Expense9.95M9.46M9.26M8.89M10.08M9.79M10.55M10.97M10.53M
NuVasive Pretax Income
Provision for Income Taxes4.81M-10.12M-4.05M-11.54M7.07M1.49M6.38M6.97M19.89M
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations11.53M-27.13M23.96M33.62M12.66M12.77M6.38M3.93M30.21M
Extraordinary Items & Discontinued Operations---------
NuVasive Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS51.96M51.74M51.86M52.79M58.33M57.79M55.91M55.78M53.16M
Average Shares used to compute Basic EPS51.36M51.23M51.09M50.75M51.08M50.57M50.39M50.16M50.03M
Income Before Nonrecurring Items30.32M20.16M29.08M26.72M24.06M20.04M27.56M21.13M20.62M
Income from Nonrecurring Items-18.79M-47.29M-5.12M6.9M-11.4M-7.27M-21.18M-17.2M9.59M
NuVasive Earnings Per Share Basic Net
NuVasive Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.580.390.560.520.460.380.530.400.40
Preferred Dividends Acc Pd---------
Dividends Common0.000.000.00------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on NuVasive stock analysis. An investor must check the following items in an income statement:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $281.56M for this quarter of 2018 Q2. Our NuVasive revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $11.53M for NUVA stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The NUVA financials along with NuVasive historical stock prices provide a lot of details about the firm.

NuVasive Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
PS Ratio (price sales ratio)
Dividend Yield

Other Income Statements - NuVasive, Inc. Industry Peers

K2M Group income statement, LDR Holding income statement, ORTHOFIX MEDICL income statement